Reinnervate announced it has signed agreements with seven new European distributors for the non-exclusive distribution of alvetex®, its 3D cell culture technology.These agreements mark a significant expansion of reinnervate’s distribution network. Under the terms of the new agreements, alve ... more
Top award for 3D cell culture pioneer, Stefan Przyborski, of Reinnervate Ltd
Prof Stefan Przyborski, CSO and founder of Reinnervate Ltd, has been recognised with a top award from the Royal Society of Chemistry.
The Rita and John Cornforth award 2012 recognises Prof. Przyborski’s leadership and inter-disciplinary work at the boundaries of physical chemistry and biology, developing Alvetex® Scaffold for three dimensional (3D) cell culture.
For the last 10 years, Prof. Przyborski’s work at the University of Durham and as CSO of Reinnervate Ltd, has lead to the development and commercialisation of solutions for scientists who wish to culture cells in a way that better mimics the in-vivo growth of cells. Under Stefan’s leadership, the scientific team at Reinnervate are now providing the global scientific community with Alvetex® Scaffold 3D cell culture protocols and application guides in areas such as 3D cancer cell biology, stem cell science, in-vitro skin modelling and 3D liver cell toxicity testing.
- cell cultures
- Royal Society of Chemistry
- cell culture technology
- cell cultivation
Scientists in Canada and the United States have developed a chip sensor for monitoring how drug candidates alter amyloid-β peptide aggregation that they hope could be used to find new treatments for Alzheimer’s disease. Research into Alzheimer’s disease has shown that the self-aggregation o ... more
Scientists in the UK have developed a new class of MRI (magnetic resonance imaging) agents that promise to deliver clearer images more quickly. Chemical shifts from proton NMR normally fall between 0-12ppm, but water and fat resonate at 4.7 and 1.3ppm respectively, causing noise that can ov ... more
Scientists in China have developed a simple microchip that enables quick and inexpensive high-throughput screening of potential drug candidates in 3D cell cultures. Scientists often use cell-based high-throughput screening in the first stage of drug design as a technique to quickly identify ... more
- 1Endress+Hauser Completes Takeover of Analytik Jena
- 2Schleicher & Schuell has been purchased by Whatman plc
- 3SCHOTT Is Now a Stock Corporation
- 4Laboratory of the future at analytica in Munich in the present
- 5The latest technologies in food and plastics analysis, bioanalysis and genetic analysis
- 6MDS Sciex Opens Manufacturing Facility in Singapore
- 7Determination of NOx-Emissions - VDI Guidline 2456
- 8GRACE ACQUIRES ALLTECH
- 9PIAB announces new Chief Executive Officer
- 10Argonne’s lithium-ion battery technology to be commercialized by BASF
- Agilent Technologies launches new platform for analyzing cell-free DNA
- Natural air standards support accurate greenhouse gas measurements
- License agreement for analytical chemistry tech signed by ORNL and SCIEX
- The world's tiniest temperature sensor is powered by radio waves
- What is it, and where did it come from?
- Neanderthals may have been infected by diseases carried out of Africa by humans
- New laser achieves wavelength long sought by laser developers
- Determining the structures of nanocrystalline pharmaceuticals by electron diffraction
- Exploiting high speed light for super slow science
- Glass cones shine new light on radially polarised beams